Moderna

@moderna_tx

Working to deliver on the promise of mRNA science to create a new class of transformative medicines for patients.

Cambridge, MA
Vrijeme pridruživanja: prosinac 2013.

Tweetovi

Blokirali ste korisnika/cu @moderna_tx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @moderna_tx

  1. proslijedio/la je Tweet
    prije 12 sati

    TODAY ONLY - Order your one-of-a-kind Valentine's Day Card set. Each set includes 18 unique cards, featuring custom art work submitted by kids nationwide. Support our kiddos and promote CMV awareness in your community!

    Poništi
  2. 3. velj
    Poništi
  3. 31. sij

    Team Moderna was honored to play on the TD Garden Parquet in support of athletes and to help kick off the 2020 season. We’re bringing it on for a great cause!

    Poništi
  4. 30. sij
    Poništi
  5. 28. sij

    Calling all creative kids! Submit your original artwork to the art contest! Your art can be about anything -- CMV awareness, inclusion, love, strength, family, or friends. Learn more & submit your art before Jan. 31:

    Poništi
  6. 28. sij

    All gowned up and ready to go! Last week we hosted more than 20 Norwood High School students to kick off our Healthcare Innovation Pathway Program. We can't wait to see what they're up to next!

    Poništi
  7. proslijedio/la je Tweet
    24. sij

    The novel () originating in China & now rapidly spreading appears to have a lower fatality rate than SARS- & MERS-CoV; the prospect of a sustained epidemic is uncertain. Classic measures (eg isolation) are a primary defense

    Poništi
  8. 23. sij

    Moderna is committed to addressing and improving global .

    Poništi
  9. 23. sij
    Poništi
  10. proslijedio/la je Tweet

    Time for a biology lesson! Tonight is sitting down with the CEO of to learn more about how this company is transforming the biotech space

    Poništi
  11. 14. sij

    Yesterday, we announced that we’ll expand our pipeline of innovative vaccines in the near term, following 6 positive Phase 1 clinical trial readouts from our portfolio & the initiation of a Phase 2 study for our vaccine (mRNA-1647)

    Poništi
  12. 14. sij

    mRNA-6981 is an encoding for PD-L1 and is designed to augment cell surface levels of PD-L1 on myeloid cells, providing co-inhibitory signals to self-reactive lymphocytes.

    Poništi
  13. 14. sij

    mRNA-6231 is an encoding for a long-acting IL-2 mutein designed to preferentially activate and expand the regulatory T cell population, dampening the immune response.

    Poništi
  14. 14. sij

    To manage risk, our approach is to leverage early programs within a modality to generate clinical data & insights that reduce the technology risk of subsequent programs & accelerate the expansion of the pipeline in that modality

    Poništi
  15. 14. sij

    We are working to address the underlying cause of metabolic disorders to enable the body to replace missing or dysfunctional proteins. The recent positive Ph 1 data from our antibody reinforces our belief that we can make an impact in

    Poništi
  16. 14. sij

    We believe our vaccine (mRNA-1647) will build Moderna’s future and embodies our mission.

    Poništi
  17. 14. sij

    Our CEO Stéphane Bancel is on stage at presenting updates on our development pipeline and recent company updates

    Poništi
  18. 13. sij

    Our CEO Stéphane Bancel is on stage at the & event for the “Secrets Behind Built-to-Last Companies: Anne Wojcicki in Conversation with 4 Gamechangers & Category Creators” panel with fellow industry leaders.

    Poništi
  19. 13. sij

    Our CEO Stéphane Bancel is participating in an panel on the art of the deal to discuss Moderna’s approach to strategic partnerships and

    Poništi
  20. 12. sij

    We also reiterated prior financial guidance for 2020

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·